重庆医学2011，Vol.40Issue(3)：262-263,2.DOI:10.3969/j.issn.1671-8348.2011.03.022
Ahmed青光眼阀植入术联合玻璃体切除术治疗新生血管性青光眼的临床研究
Clinical research of Ahmed glaucoma valve implant combined with vitrectomy for neovascular glaucoma
摘要
Abstract
Objective To evaluate the effects of Ahmed glaucoma valve implant combined with vitrectomy for neovascular glau coma(NVG). Methods 34 patients (36 eyes)with NVG were undergone vitrectomy and Ahmed glaucoma valve implant. Results Mean preoperative IOP was 36.87 mm Hg (25-58 mm Hg)and 13.59 mm Hg (9-23.64 mm Hg)postoperatively,and mean number hypotensive drugs was decreased from 2.82 (2-5) before surgery to 0.64 (0-2)after it. Visual acuity in 25 eyes were improved in varying degree. There were 7 eyes of each of the following adverse events: bullous keratopathy(2 eyes),detachment of choroid(2 eyes), iatrogenic cataract (1 eye), hemorrhage of vitreous cavity glaucoma (1 eye), valve exposure (1 eye). Conclusion Ahmed glaucoma valve implant combined with vitrectomy seems to be a viable and safe surgical option in the management of NVG.关键词
玻璃体切除术/玻璃体,Ahmed青光眼阀植入/新生血管性青光眼Key words
vitrectomy/ vitreous body/ Ahmed glaucoma valve implant/ neovascular glaucoma引用本文复制引用
李马号,李世宏..Ahmed青光眼阀植入术联合玻璃体切除术治疗新生血管性青光眼的临床研究[J].重庆医学,2011,40(3):262-263,2.
